Paramagnetic rim sign in multiple sclerosis
https://doi.org/10.14412/2074-2711-2023-4-94-99
Abstract
To date, there is no accepted highly specific pattern for the detection of multiple sclerosis. Correct diagnosis is particularly difficult in situations where an atypical clinical picture of the disease is observed or nonstandard neuroimaging patterns are detected. Therefore, the scientific community has high hopes for the discovery of new markers that will allow clarification of the diagnosis in controversial cases. Currently, there is a lot of research focused on the study of an additional diagnostic MRI pattern – a sign of a paramagnetic rim. This symptom is associated with chronic smoldering central nervous system (CNS) lesions, is more commonly seen in young males, is found primarily in the periventricular region, and is also a promising predictor of disability and cognitive impairment. There is evidence that it is present in earlier stages of disease in “fresh” lesions of the CNS. However, further studies are needed to use this diagnostic MRI pattern in clinical practice.
About the Authors
D. V. Kapkanets
Department of Neurology, Neurosurgery and Medical Genetics of N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Danila Vadimovich Kapkanets
1, Ostrovityanova St., Moscow 117997
S. E. Belov
Department of Neurology, Neurosurgery and Medical Genetics of N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
1, Ostrovityanova St., Moscow 117997
M. B. Dolgushin
Department of Neuroimmunology, Institute of Clinical Neurology,
Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia
Russian Federation
Russian Federation
1, Ostrovityanova St., Build. 10, Moscow117997
A. N. Boyko
Department of Neurology, Neurosurgery and Medical Genetics of N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Department of Neuroimmunology, Institute of Clinical Neurology,
Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia
Russian Federation
Russian Federation
1, Ostrovityanova St., Moscow 117997
1, Ostrovityanova St., Build. 10, Moscow117997
References
1. Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med. 2018 Jan 11;378(2):169-80. doi: 10.1056/NEJMra1401483
2. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009 May;132(Pt 5):1175-89. doi: 10.1093/brain/awp070. Epub 2009 Mar 31.
3. Kipp M, van der Star B, Vogel DY, et al. Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond. Mult Scler Relat Disord. 2012 Jan;1(1):15-28. doi: 10.1016/j.msard.2011.09.002. Epub 2011 Sep 16.
4. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366
5. Solomon AJ, Bourdette DN, Cross AH, et al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.
6. Fadda G, Brown RA, Longoni G, et al; Canadian Pediatric Demyelinating Disease Network. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study. Lancet Child Adolesc Health. 2018 Mar;2(3):191-204. doi: 10.1016/S2352-4642(18)30026-9. Epub 2018 Feb 1.
7. Filippi M, Preziosa P, Meani A, et al; MAGNIMS Study Group. Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study. Neurology. 2022 Jan 4;98(1):e1-e14. doi: 10.1212/WNL.0000000000013016. Epub 2021 Oct 29.
8. Hyun JW, Kim W, Huh SY, et al. Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome. Mult Scler. 2019 Oct;25(11):1488-95. doi: 10.1177/1352458518790702. Epub 2018 Jul 25.
9. Van der Vuurst de Vries RM, Mescheriakova JY, Wong YYM, et al. Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome. JAMA Neurol. 2018 Nov 1;75(11):1392-8. doi: 10.1001/jamaneurol.2018.2160
10. Wong YYM, de Mol CL, van der Vuurst de Vries RM, et al. Real-world validation of the 2017 McDonald criteria for pediatric MS. Neurol Neuroimmunol Neuroinflamm. 2018 Dec 14;6(2):e528. doi: 10.1212/NXI.0000000000000528
11. Solomon AJ, Naismith RT, Cross AH.Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice. Neurology. 2019 Jan 1;92(1):26-33. doi: 10.1212/WNL.0000000000006583. Epub 2018 Oct 31.
12. Solomon AJ, Pettigrew R, Naismith RT, et al.Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria. Mult Scler. 2021 Feb;27(2):250-8. doi: 10.1177/1352458520910496. Epub 2020 Mar 12.
13. Wattjes MP, Ciccarelli O, Reich DS, et al; Magnetic Resonance Imaging in Multiple Sclerosis study group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group. 2021 MAGNIMS-CMSCNAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021 Aug;20(8):653-70. doi: 10.1016/S1474-4422(21)00095-8. Epub 2021 Jun 14.
14. Sati P, George IC, Shea CD, et al. FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology. 2012 Dec;265(3):926-32. doi: 10.1148/radiol.12120208. Epub 2012 Oct 16.
15. Absinta M, Nair G, Monaco MCG, et al.The “central vein sign” in inflammatory demyelination: The role of fibrillar collagen type I. Ann Neurol. 2019 Jun;85(6):934-42. doi: 10.1002/ana.25461. Epub 2019 Mar 30.
16. Cortese R, Magnollay L, Tur C, et al. Valueof the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. 2018 Apr 3;90(14):e1183-e1190. doi: 10.1212/WNL.0000000000005256. Epub 2018 Mar 7.
17. Kilsdonk ID, Wattjes MP, Lopez-Soriano A,et al. Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. Eur Radiol. 2014 Apr;24(4):841-9. doi: 10.1007/s00330-013-3080-y. Epub 2013 Dec 9.
18. Maggi P, Absinta M, Grammatico M, et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. 2018 Feb;83(2):283-94. doi: 10.1002/ana.25146. Epub 2018 Feb 15.
19. Sati P, Oh J, Constable RT, et al; NAIMSCooperative. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016 Dec;12(12):714-22. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11.
20. Sinnecker T, Clarke MA, Meier D, et al;MAGNIMS Study Group. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis. JAMA Neurol. 2019 Dec 1;76(12):1446-56. doi: 10.1001/jamaneurol.2019.2478. Erratum in: JAMA Neurol. 2020 Aug 1;77(8):1040.
21. Dal-Bianco A, Grabner G, Kronnerwetter C, et al. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.
22. Hametner S, Wimmer I, Haider L, et al.Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol. 2013 Dec;74(6):848-61. doi: 10.1002/ana.23974. Epub 2013 Oct 7.
23. Absinta M, Reich DS, Filippi M. Springcleaning: time to rethink imaging research lines in MS? J Neurol. 2016 Oct;263(10):1893-902. doi: 10.1007/s00415-016-8060-0. Epub 2016 Feb 17.
24. Absinta M, Sati P, Schindler M, et al.Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest. 2016 Jul 1;126(7):2597-609. doi: 10.1172/JCI86198. Epub 2016 Jun 6.
25. Kaunzner UW, Kang Y, Zhang S, et al. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain. 2019 Jan 1;142(1):133-45. doi: 10.1093/brain/awy296
26. Absinta M, Sati P, Masuzzo F, et al. Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo. JAMA Neurol. 2019 Dec 1;76(12):1474-83. doi: 10.1001/jamaneurol.2019.2399. Erratum in: JAMA Neurol. 2019 Dec 1;76(12):1520.
27. Meaton I, Altokhis A, Allen CM, et al.Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis. Mult Scler. 2022 Dec;28(14):2212-20. doi: 10.1177/13524585221118677. Epub 2022 Aug 26.
28. Clarke MA, Pareto D, Pessini-Ferreira L, et al. Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis. AJNR Am J Neuroradiol. 2020 Jun;41(6):1001-8. doi: 10.3174/ajnr.a6547. Epub 2020 May 21.
29. Maggi P, Sati P, Nair G, et al. ParamagneticRim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study. Ann Neurol. 2020 Nov;88(5):1034-42. doi: 10.1002/ana.25877. Epub 2020 Sep 9.
30. Hametner S, Dal Bianco A, Trattnig S,Lassmann H. Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with Ultra-high field magnetic resonance imaging. Brain Pathol. 2018 Sep;28(5):743-9. doi: 10.1111/bpa.12643
31. Absinta M, Sati P, Fechner A, et al. Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI. AJNR Am J Neuroradiol. 2018 Jul;39(7):1233-8. doi: 10.3174/ajnr.A5660. Epub 2018 May 3.
32. Kilsdonk ID, Lopez-Soriano A, Kuijer JP,et al. Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics. J Neurol. 2014 Jul;261(7):1356-64. doi: 10.1007/s00415-014-7351-6. Epub 2014 Apr 29.
33. Sinnecker T, Dörr J, Pfueller CF, et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology. 2012 Aug 14;79(7):708-14. doi: 10.1212/WNL.0b013e3182648bc8. Epub 2012 Aug 1.
34. Suthiphosuwan S, Sati P, Absinta M, et al. Paramagnetic Rim Sign in Radiologically Isolated Syndrome. JAMA Neurol. 2020 May 1;77(5):653-5. doi: 10.1001/jamaneurol.2020.0124
35. Tillema JM, Weigand SD, Dayan M, et al. Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis. AJNR Am J Neuroradiol. 2018 Jun;39(6):10528. doi: 10.3174/ajnr.A5636. Epub 2018 Apr 26.
36. Frischer JM, Weigand SD, Guo Y, et al.Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.
37. Suthiphosuwan S, Sati P, Guenette M, et al. The Central Vein Sign in Radiologically Isolated Syndrome. AJNR Am J Neuroradiol. 2019 May;40(5):776-83. doi: 10.3174/ajnr.A6045. Epub 2019 Apr 18.
38. Tolaymat B, Zheng W, Chen H, et al. Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping. Mult Scler Relat Disord. 2020 Oct;45:102317. doi: 10.1016/j.msard.2020.102317. Epub 2020 Jun 18.
39. Luchetti S, Fransen NL, van Eden CG, et al. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol. 2018 Apr;135(4):511-28. doi: 10.1007/s00401-018-1818-y. Epub 2018 Feb 13.
40. Yao B, Ikonomidou VN, Cantor FK, et al. Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*-Weighted Imaging at 7.0 Tesla. J Neuroimaging. 2015 SepOct;25(5):799-806. doi: 10.1111/jon.12193. Epub 2015 Feb 6.
41. Li X, Harrison DM, Liu H, et al. Magneticsusceptibility contrast variations in multiple sclerosis lesions. J Magn Reson Imaging. 2016 Feb;43(2):463-73. doi: 10.1002/jmri.24976. Epub 2015 Jun 14.
42. Oh J, Suthiphosuwan S, Sati P, et al.Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS. Mult Scler. 2021 Dec;27(14):2199-208. doi: 10.1177/13524585211002097. Epub 2021 Mar 23.
43. Absinta M, Sati P, Gaitan MI, et al. Seventesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol. 2013 Nov;74(5):669-78. doi: 10.1002/ana.23959. Epub 2013 Sep 16.
44. Absinta M, Bhagavatheeshwaran G, Sati P.Longitudinal MRI history of lesion repair based on the presence or absence of a 7t paramagnetic RIM; Proceedings of the 3rd Annual Americas Committee for Treatment and Research in Multiple Sclerosis Forum, ACTRIMS 2018; SAGE Publications Ltd.; 1–3 February 2018. P. 62. doi: 10.1177/1352458517750967
45. AlTokhis AI, AlOtaibi AM, Felmban GA, et al. Iron Rims as an Imaging Biomarker in MS: A Systematic Mapping Review. Diagnostics (Basel). 2020 Nov 18;10(11):968. doi: 10.3390/diagnostics10110968
46. Bian W, Harter K, Hammond-Rosenbluth KE, et al. A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler. 2013 Jan;19(1):69-75. doi: 10.1177/1352458512447870. Epub 2012 May 28.
47. Chawla S, Kister I, Sinnecker T, et al.Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging. PLoS One. 2018 Sep 13;13(9):e0202918. doi: 10.1371/journal.pone.0202918
48. Chen W, Gauthier SA, Gupta A, et al.Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology. 2014 Apr;271(1):183-92. doi: 10.1148/radiol.13130353. Epub 2013 Nov 18.
49. Wiggermann V, Hernandez Torres E,Vavasour IM, et al. Magnetic resonance frequency shifts during acute MS lesion formation. Neurology. 2013 Jul 16;81(3):211-8. doi: 10.1212/WNL.0b013e31829bfd63. Epub 2013 Jun 12.
50. Yablonskiy DA, Luo J, Sukstanskii AL, et al.Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis. Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):14212-7. doi: 10.1073/pnas.1206037109. Epub 2012 Aug 13.
51. Schwartz KM, Erickson BJ, Lucchinetti C.Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology. 2006 Mar;48(3):143-9. doi: 10.1007/s00234-0050024-5. Epub 2006 Jan 31.
52. Llufriu S, Pujol T, Blanco Y, et al. T2 hypointense rims and ring-enhancing lesions in MS. Mult Scler. 2010 Nov;16(11):1317-25. doi: 10.1177/1352458510377905. Epub 2010 Aug 4.
53. Kantarci OH, Lebrun C, Siva A, et al. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome. Ann Neurol. 2016 Feb;79(2):288-94. doi: 10.1002/ana.24564. Epub 2015 Dec 29.
54. Okuda DT, Siva A, Kantarci O, et al; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclerose en Plaques (CFSEP). Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509
55. Kaisey M, Solomon AJ, Luu M, et al.Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers. Mult Scler Relat Disord. 2019 May;30:51-6. doi: 10.1016/j.msard.2019.01.048. Epub 2019 Feb 2.
56. Chawla S, Kister I, Wuerfel J, et al. Ironand Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI. AJNR Am J Neuroradiol. 2016 Jul;37(7):1223-30. doi: 10.3174/ajnr.A4729. Epub 2016 Mar 24.
57. Wuerfel J, Sinnecker T, Ringelstein EB, et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler. 2012 Nov;18(11):1592-9. doi: 10.1177/1352458512441270. Epub 2012 Jun 18.
58. Hosseini Z, Matusinec J, Rudko DA, et al.Morphology-Specific Discrimination between MS White Matter Lesions and Benign White Matter Hyperintensities Using Ultra-High-Field MRI. AJNR Am J Neuroradiol. 2018 Aug;39(8):1473- 9. doi: 10.3174/ajnr.A5705. Epub 2018 Jun 21.
Review
For citations:
Kapkanets DV, Belov SE, Dolgushin MB, Boyko AN. Paramagnetic rim sign in multiple sclerosis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(4):94–99. (In Russ.) https://doi.org/10.14412/2074-2711-2023-4-94-99
Views:
325
Email this article 